Company / Financials
Regenerative Medical Technology Group Inc. Financials
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$5.1M
FY2025 · +24.2% YoY
Net Income
-$7.8M
FY2025 · -40.4% YoY
Profit Margin
-153.2%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$4.5M
FY2025
Total Debt
$4
-0.00x debt/equity
Equity
-$34.7M
FY2025
ROA
-174.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -19.75 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$5.1M+24.2% YoYNet Income HistoryProfit after all expenses and taxes-$7.8M-40.4% YoYGross Profit HistoryRevenue minus cost of goods sold$2.8M-0.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$2.3M+78.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$867.2K-1168.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.1M+40.3% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense-$1.6M-41.1% YoYEPS (Basic) HistoryBasic earnings per share-$0.44+44.3% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.44+44.3% YoY